Terms: = Liver cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Diagnosis
3 results:
1. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients.
Liu Y; Shen B; Huang T; Wang J; Jiang J
PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019
[TBL] [Abstract] [Full Text] [Related]
2. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract] [Full Text] [Related]
3. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis.
Cangul H; Salnikow K; Yee H; Zagzag D; Commes T; Costa M
Cell Biol Toxicol; 2002; 18(2):87-96. PubMed ID: 12046693
[TBL] [Abstract] [Full Text] [Related]
